{"transactions":[{"id":2610254,"issuer":{"id":110669,"kind":"organization","name":"DA32 Life Science Tech Acquisition Corp.","symbol":"DALS"},"owners":[{"id":136504,"kind":"person","name":"Section 32 Fund 3, LP","position":1,"cik":"0001808115","reported_name":"Section 32 Fund 3, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":136505,"kind":"person","name":"Section 32 GP 3, LLC","position":2,"cik":"0001808116","reported_name":"Section 32 GP 3, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2021-08-09T21:54:10.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On August 5, 2021, the Reporting Persons forfeited 30,000 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the IPO disclosing all material information about the Issuer and the IPO."},{"field":"shares","element":"transactionShares","label":"F5","text":"On August 5, 2021, the Reporting Persons forfeited 30,000 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the IPO disclosing all material information about the Issuer and the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"This Form 4 is filed jointly by Section 32 Fund 3, LP (\"S32 Fund\"), Section 32 GP 3, LLC (\"S32 GP\") and William J. Maris (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."}],"balance_after":4665000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-21-032284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863294/000089924321032284/doc4.xml","form_type":"4"}},{"id":2610253,"issuer":{"id":110669,"kind":"organization","name":"DA32 Life Science Tech Acquisition Corp.","symbol":"DALS"},"owners":[{"id":136504,"kind":"person","name":"Section 32 Fund 3, LP","position":1,"cik":"0001808115","reported_name":"Section 32 Fund 3, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":136505,"kind":"person","name":"Section 32 GP 3, LLC","position":2,"cik":"0001808116","reported_name":"Section 32 GP 3, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock, par value $0.0001 per share","published_at":"2021-08-09T21:54:10.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":701250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Through DA32 Sponsor LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 5, 2021, DA32 Sponsor LLC (\"Sponsor\") forfeited 701,250 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the \"IPO\") disclosing all material information about the Issuer and the IPO."},{"field":"shares","element":"transactionShares","label":"F2","text":"On August 5, 2021, DA32 Sponsor LLC (\"Sponsor\") forfeited 701,250 shares of Class B Common Stock to the Issuer for no consideration, which was exempted pursuant to Rule 16b-3(e) under the Securities Exchange Act of 1934, as amended, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Persons' control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the \"IPO\") disclosing all material information about the Issuer and the IPO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Shares\" in the Issuer's Registration Statement on Form S-1 File No. 333-257679) (the \"Registration Statement\") and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is filed jointly by Section 32 Fund 3, LP (\"S32 Fund\"), Section 32 GP 3, LLC (\"S32 GP\") and William J. Maris (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Sponsor is the record holder of the securities reported herein. As a managing member of Sponsor, S32 Fund may be deemed to beneficially own the securities owned directly by Sponsor. As the general partner of S32 Fund, S32 GP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole Managing Member of S32 GP, William J. Maris may be deemed to beneficially own securities owned directly by Sponsor."}],"balance_after":4695000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":701250},"source":{"system":"sec-edgar","filing":"0000899243-21-032284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863294/000089924321032284/doc4.xml","form_type":"4"}},{"id":2618156,"issuer":{"id":110669,"kind":"organization","name":"DA32 Life Science Tech Acquisition Corp.","symbol":"DALS"},"owners":[{"id":136504,"kind":"person","name":"Section 32 Fund 3, LP","position":1,"cik":"0001808115","reported_name":"Section 32 Fund 3, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":136505,"kind":"person","name":"Section 32 GP 3, LLC","position":2,"cik":"0001808116","reported_name":"Section 32 GP 3, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-03T21:47:10.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":650000,"price":10,"value":6500000.0,"ownership":{"direct":false,"nature":"Through DA32 Sponsor LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"DA32 Sponsor LLC (\"Sponsor\") purchased 650,000 private placement shares of the Issuer directly from the Issuer for $10.00 per share, concurrently with the Issuer's initial public offering. This purchase was exempted pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed jointly by Section 32 Fund 3, LP (\"S32 Fund\"), Section 32 GP 3, LLC (\"S32 GP\") and William J. Maris (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Sponsor is the record holder of the securities reported herein. As a managing member of Sponsor, S32 Fund may be deemed to beneficially own the securities owned directly by Sponsor. As the general partner of S32 Fund, S32 GP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole Managing Member of S32 GP, William J. Maris may be deemed to beneficially own securities owned directly by Sponsor."}],"balance_after":1450000,"source":{"system":"sec-edgar","filing":"0000899243-21-031450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863294/000089924321031450/doc4.xml","form_type":"4"}},{"id":2618155,"issuer":{"id":110669,"kind":"organization","name":"DA32 Life Science Tech Acquisition Corp.","symbol":"DALS"},"owners":[{"id":136504,"kind":"person","name":"Section 32 Fund 3, LP","position":1,"cik":"0001808115","reported_name":"Section 32 Fund 3, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":136505,"kind":"person","name":"Section 32 GP 3, LLC","position":2,"cik":"0001808116","reported_name":"Section 32 GP 3, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":86808,"kind":"person","name":"Maris William J","position":3,"cik":"0001722210","reported_name":"Maris William J","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2021-08-03T21:47:10.000Z","date":"2021-07-30","kind":"purchase","acquired":true,"shares":800000,"price":10,"value":8000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Section 32 Fund 3, LP purchased 800,000 shares of the Issuer's Class A common stock for $10.00 per share in the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is filed jointly by Section 32 Fund 3, LP (\"S32 Fund\"), Section 32 GP 3, LLC (\"S32 GP\") and William J. Maris (collectively, the \"Reporting Persons\"). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein."}],"balance_after":800000,"source":{"system":"sec-edgar","filing":"0000899243-21-031450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863294/000089924321031450/doc4.xml","form_type":"4"}}]}